Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Advanced Cancer × sargramostim × Clear all

Sponsor

Conditions

Leukemia 16 Lymphoma 10 Leukemia, Myeloid, Acute 9 Breast Neoplasms 9 Neuroblastoma 8 Myelodysplastic Syndromes 8 Leukemia, Lymphocytic, Chronic, B-Cell 8 Ovarian Neoplasms 7 Lymphoma, Follicular 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Multiple Myeloma 6 Melanoma 6 Prostatic Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasm Metastasis 4 Glioblastoma 4 Fallopian Tube Neoplasms 4 Osteosarcoma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Ganglioneuroblastoma 3 Colorectal Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Neoplasms 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lung Neoplasms 2 Leukemia, Myeloid, Chronic-Phase 2 Hodgkin Disease 2 Gliosarcoma 2

Interventions

Nivolumab 7 linrodostat 3 Ipilimumab 3 relatlimab 2 Pemetrexed 2 tislelizumab 1 regorafenib 1 ralimetinib 1 p38 Mitogen-Activated Protein Kinases 1 figitumumab 1 efatutazone 1 abemaciclib 1 Vorinostat 1 Tamoxifen 1 Sunitinib 1 Ranitidine 1 Midazolam 1 LY2603618 1 LY2584702 1 Gemcitabine 1 Fulvestrant 1 Dasatinib 1 Crizotinib 1 Cetuximab 1 Carboplatin 1 BMS-813160 1 3-(9-fluoro-2-(piperidin-1-ylcarbonyl)-1,2,3,4-tetrahydro(1,4)diazepino(6,7,1-hi)indol-7-yl)-4-imidazo(1,2-a)pyridin-3-yl-1H-pyrrole-2,5-dione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡